bisindolylmaleimide i has been researched along with Autoimmune Diabetes in 2 studies
bisindolylmaleimide I: a bis(indolyl)maleimide
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Vetri, F | 1 |
| Qi, M | 1 |
| Xu, H | 1 |
| Oberholzer, J | 1 |
| Paisansathan, C | 1 |
| Hyun, E | 1 |
| Ramachandran, R | 1 |
| Cenac, N | 1 |
| Houle, S | 1 |
| Rousset, P | 1 |
| Saxena, A | 1 |
| Liblau, RS | 1 |
| Hollenberg, MD | 1 |
| Vergnolle, N | 1 |
2 other studies available for bisindolylmaleimide i and Autoimmune Diabetes
| Article | Year |
|---|---|
Impairment of neurovascular coupling in Type 1 Diabetes Mellitus in rats is prevented by pancreatic islet transplantation and reversed by a semi-selective PKC inhibitor.
Topics: Animals; Arterioles; Benzimidazoles; Cardiovascular Agents; Diabetes Mellitus, Experimental; Diabete | 2017 |
Insulin modulates protease-activated receptor 2 signaling: implications for the innate immune response.
Topics: Animals; Calcium; Cell Line; Cells, Cultured; Chromones; Diabetes Mellitus, Type 1; Endothelial Cell | 2010 |